All lobbying filings
FEDERAL STREET STRATEGIES, LLC
Lobbying for ABBVIE, INC. · Biopharmaceutical Research & Development Company.
Filing
2nd Quarter - Report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 21, 2025
Income
$50,000.00
What the client paid this registrant for the period.
Client based in
District of Columbia
Lobbyists on this filing
5
-
PAUL BRATHWAITEPreviously held: Executive Director, Congressional Black Caucus; Deputy Assistant Secretary, ESA, U.S. Department of Labor; Special Assistant to the Secretary, U.S. Department of Labor.
-
VEN NERALLA New on this filingPreviously held: Chief of Staff, U.S. Rep. Andy Levin; Deputy Chief of Staff, U.S. Rep. Pramila Jayapal; Legislative Director, U.S. Rep. Barbara Lee; Legislative Assistant, U.S. Rep. Peter DeFazio; Senior Advisor, USDA; OPP; and MCC.
-
STACEY LEAVANDOSKY New on this filingPreviously held: Chief of Staff, U.S. Representative Zoe Lofgren; Senior Advisor, Committee on Science, Space & Technology; Senior Advisor, Committee on House Administration; Executive Director, California Democratic Congressional Delegation
-
KAADE WALLACE New on this filingPreviously held: Legislative Correspondent, U.S. Senator Amy Klobuchar; Staff Assistant, U.S. Representative Betty McCollum
-
MARGAUX OCHOA New on this filingPreviously held: Office of the Vice President, President, U.S. Senate
Government bodies contacted
2
Lobbying activity
2
Patient Access to drug treatment therapies; and drug cost and drug pricing reform. Oversight of the pharmaceutical industry and drug pricing. Monitoring policies as they relate to PBMs Monitor issues related to the FY2025 budget reconciliation process
Medicare Part D policies. Monitoring Policies related to the 340b program. Issues related to the implementation of the Inflation Reduction Act Monitor issues related to the FY2025 budget reconciliation process